Chtillon, France, April 25, 2024 Combined General Meeting of May 16, 2024 Procedures for Obtaining Information and Preparatory Documents for the Combined General Meeting DBV Technologies...
...
DBV Technologies announces filing of 2023 Annual Report
DBV Technologies Reports Full Year 2023 Financial Results and Business Update
DBV Technologies to Report Full Year 2023 Financial Results
Montrouge, France, February 20 2024 DBV Technologies to Participate in Upcoming AAAAI 2024 Congress DBV Technologies (Euronext: DBV ISIN: FR0010417345 NASDAQ: DBVT), a clinical-stage...
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
Montrouge, France, November 9, 2023 DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of Viaskin„¢ Peanut in Toddlers Viaskin Peanut...
Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023 (Article 223-16 of the General Regulations of the Autorité des...
Montrouge, France, November 2, 2023 DBV Technologies to Present New Data at ACAAI 2023 New data to include late-breaking abstract detailing interim 12-month results from the ongoing Phase 3...